Explorer With Large Yukon Land Package 'Has an Exceptional Future'
Source: Streetwise Reports  (8/6/21)
In a recent Crescat Capital broadcast, Geologic and Technical Director, Dr. Quinton Hennigh introduced a new exploration company, Snowline Gold, and provided an update on seven other exploration companies, all in Crescat Capital's mining exploration portfolio.
More >

Gold Miner Posts Q2/21 Financial, Operational Beat, 2021 Numbers Look Good
Source: Streetwise Reports  (8/6/21)
A report by CIBC contains its full-year 2021 estimates for top pick, Endeavour Mining. More >

Top Pick Uranium Company Delivers 'Strong Sales and Production Beat' in Q2/21
Source: Streetwise Reports  (8/6/21)
Kazatomprom's quarterly outperformance and numbers were analyzed in a BMO Capital Markets report. More >

Is 2021 the Breakout Year for This Yukon Explorer?
Source: Streetwise Reports  (8/5/21)
Golden Sky Minerals is mobilizing for a summer of drilling in the Yukon, while acquiring additional projects. More >

Adrian Day: Two Silver Company 'Best Buys'
Source: Adrian Day for Streetwise Reports  (8/5/21)
In Adrian Day's Global Analyst, Adrian Day reviews recent developments and earnings reports at several companies, including some with high yields. More >

Precision Mapping Firm's Shares Granted DTC Eligibility
Source: Streetwise Reports  (8/5/21)
ProStar Holdings advised that its common shares have been deemed to be DTC Eligible by The Depository Trust Co. of New York. More >

Kincora Copper: Cheap Entry into Australia's Foremost Porphyry Copper-Gold Belt in NSW
Source: Peter Epstein for Streetwise Reports  (8/5/21)
Peter Epstein of Epstein Research speaks with Kincora Copper CEO Sam Spring about his company's exploration plans. More >

US-Based Biopharma 'In Full Reset Mode,' Analyst Says
Source: Streetwise Reports  (8/4/21)
An H.C. Wainwright & Co. report notes that Agios Pharmaceuticals "is rapidly rebooting and has made critical progress on various fronts." More >

Biopharma Makes 'Solid Clinical Progress' in Q2/21
Source: Streetwise Reports  (8/4/21)
The highlights of Oryzon Genomics' Q2/21 clinical advancements were recapped in a Roth Capital Partners report. More >

Royalty Company Secures 'Milestone' Agreement with Miner
Source: Maurice Jackson for Streetwise Reports  (8/4/21)
Maurice Jackson of Proven and Probable talks with David Cole, CEO of EMX Royalty, about the company's latest royalty portfolio purchase agreement. More >

Veteran Geologist to Serve as Technical Advisor for Gold Explorer
Source: Streetwise Reports  (8/4/21)
Kalo Gold Holdings Corp. reported it has enlisted gold mining executive Paul Harbidge to join the company as a technical advisor and advisory committee member. More >

Sassy Resources Killing It in Gold Exploration on Both Canadian Coasts
Source: Peter Epstein for Streetwise Reports  (8/4/21)
Peter Epstein of Epstein Research takes a deep dive into Sassy Resources, which he believes has two company-making project portfolios. More >

Novavax Shares Get a Boost as EC Orders up to 200 Million Doses of Its COVID-19 Vaccine
Source: Streetwise Reports  (8/4/21)
Novavax Inc. shares traded nearly 19% higher after the company reported the finalization of an advance purchase agreement with the European Commission to provide up to 200 million doses of its COVID-19 Vaccine. More >

'Top Pick' Cleantech Firm Reconfigures Existing Technology to Simplify Electric Vehicle Charging
Source: Streetwise Reports  (8/3/21)
A Haywood report noted that this new use for Exro Technologies' coil driver has "important indications to cost reduction" on both the vehicle and infrastructure sides. More >

Drilling of Papua New Guinea Deposit Returns 'Appreciable Widths,' 'High Grades a Plenty'
Source: Streetwise Reports  (8/3/21)
A Haywood report explains the positive drill results from K92 Mining's Kora. More >

Mining Major Achieves Solid H1/21, 'Shareholder Returns Take Center Stage'
Source: Streetwise Reports  (8/3/21)
Rio Tinto's H1/21 cash flow, various EBITDA numbers, interim dividend and recent funding are covered in a BMO Capital Markets report. More >

Translate Bio Shares Rise 29% on Sanofi's $3.2 Billion Buyout Bid
Source: Streetwise Reports  (8/3/21)
Shares of Translate Bio Inc. soared to a new 52-week high after the company reported it agreed to be acquired by its collaborative partner Sanofi SA for $38 per share in cash in a deal valued at $3.2 billion. More >

Gold Prepares to Rally
Source: Peter Krauth for Streetwise Reports  (8/3/21)
Peter Krauth of Gold Resource Investor looks at macroeconomic factors and explains why he believes gold and gold stocks are good buys right now. More >

This $50 Million Company Is About to Change a $12.5 Billion Market—Guess What Happens Next
Source: Matt Badiali for Streetwise Reports  (8/2/21)
Independent financial analyst Matt Badiali discusses Bion Environmental Technologies' game-changing technology and explains why he believes the company is an "overnight success about to happen." More >

Gene Editing May Terminate Virus Transmission, Combat Heart and Brain Disease With a Single Shot
Source: McAlinden Research for Streetwise Reports  (8/2/21)
McAlinden Research Partners explores the acceleration of gene-editing technology and notes the market is poised to expand as the World Health Organization (WHO) creates new standards for companies to follow. More >

Explorer Hot on the Trail of Zinc in Spain
Source: Streetwise Reports  (8/2/21)
As Emerita Resources moves ahead with exploring one high-grade project, a case moving through the Spanish courts may lead it to being awarded another. More >

Silver Miner Advances Flagship Asset in Idaho
Source: Maurice Jackson for Streetwise Reports  (8/2/21)
Maurice Jackson of Proven and Probable discusses the latest news from Lakewood Exploration with the company's president. More >

Annovis Shares Rise on Positive Phase 2 Alzheimer's and Parkinson's Disease Trial Results
Source: Streetwise Reports  (8/2/21)
Shares of Annovis Bio Inc. traded 20% higher after the company reported positive interim data from its Phase 2 clinical studies of ANVS401 (Posiphen) for treatment of Alzheimer's and Parkinson's diseases. More >

Atlassian Shares Gain 22% After Firm Posts 30% Growth in Q4 Revenue
Source: Streetwise Reports  (7/30/21)
Shares of Atlassian Corp. Plc. reached a new 52-week high after the company reported FY/21 financial results that included a 50% increase in year-over-year subscription revenue in Q4/21. More >

Trial Could Position Eco-Friendly Fertilizer for Organic Cannabis Market
Source: Streetwise Reports  (7/30/21)
Bion Environmental's leading-edge technology enters two university trials; one could lead to a breakthrough in growing organic cannabis and the other to cost-effective organic and sustainable corn-finished beef production. More >